Articles in News
San Diego biotech ViaCyte grows insulin-producing cells from human embryonic stem cells.
The week started amid anticipation of a new round of public debuts, with six of the 11 companies queued up coming from the life sciences, according to Renaissance Capital. Then on Tuesday, the…
[[Click headline to continue reading.]]
Obesity-linked inflammation can lead to type 2 diabetes
Salk Institute scientists have discovered a new tumor suppressor gene.
The nuclear receptor called RXR controls angiogenesis.
Treatment of Type 2 diabetes — one of the country’s biggest health challenges — could be improved dramatically as a result of two related discoveries made by San Diego scientists.
LA JOLLA—Scientists at the Salk Institute have identified a gene responsible for stopping the movement of cancer from the lungs to other parts of the body, indicating a new way to fight one of the world’s deadliest cancers.
San Diego-based Illumina Inc. has acquired Myraqa, a regulatory and quality consulting firm specializing in in vitro diagnostics, particularly companion diagnostics, Illumina announced.
The University of California, San Diego has been ranked the 20th best university in the world by the Center for the World University Rankings (CWUR) which measures universities’ quality of research, faculty, influence, enterprise and successful alumni.
Friends of the Institute came together on May 31 for a special fundraiser benefiting The Rocket Fund, a unique trust established at Sanford-Burnham dedicated to finding treatments for rare and neglected childhood diseases, such as congenital disorders of glycosylation (CDG). CDG is actually a group of 50 or more rare diseases caused by inherited defects